FCRL1 immunoregulation in B cell development and malignancy

FCRL1 immunoregulation in B cell development and malignancy

Immunotherapeutic targeting of surface regulatory proteins and pharmacologic inhibition of critical signaling pathways has dramatically shifted our approach to the care of individuals with B cell malignancies. This evolution in therapy reflects the central role of the B cell receptor (BCR) signaling...

Full description

Bibliographic Details
Main Authors: Murali K. Mamidi, Jifeng Huang, Kazuhito Honjo, Ran Li, Edlue M. Tabengwa, Indira Neeli, Nar’asha L. Randall, Manasa V. Ponnuchetty, Marko Radic, Chuen-Miin Leu, Randall S. Davis
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
FCRL1
B cells
lymphocyte development
B cell receptor
signaling
malignancy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1251127/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1251127/full

Similar Items